[HTML][HTML] Prospective of 68Ga-radiopharmaceutical development
I Velikyan - Theranostics, 2014 - ncbi.nlm.nih.gov
Abstract Positron Emission Tomography (PET) experienced accelerated development and
has become an established method for medical research and clinical routine diagnostics on …
has become an established method for medical research and clinical routine diagnostics on …
Somatostatin receptor PET/CT in neuroendocrine tumours: update on systematic review and meta-analysis
H Geijer, LH Breimer - European journal of nuclear medicine and …, 2013 - Springer
Purpose Neuroendocrine tumours (NET) are uncommon and may be localized in many
different places in the body. Traditional imaging has mainly been performed with CT and …
different places in the body. Traditional imaging has mainly been performed with CT and …
ENETS consensus guidelines for the standards of care in neuroendocrine tumors: radiological, nuclear medicine and hybrid imaging
A Sundin, R Arnold, E Baudin, JB Cwikla… - …, 2017 - karger.com
Contrast-enhanced computed tomography (CT) of the neck-thorax-abdomen and pelvis,
including 3-phase examination of the liver, constitutes the basic imaging for primary …
including 3-phase examination of the liver, constitutes the basic imaging for primary …
Appropriate use criteria for somatostatin receptor PET imaging in neuroendocrine tumors
TA Hope, EK Bergsland, MF Bozkurt… - Journal of Nuclear …, 2018 - Soc Nuclear Med
Somatostatin receptor (SSTR) PET has demonstrated a significant improvement over
conventional imaging (CI) in patients with neuroendocrine tumors (NETs). SSTR PET should …
conventional imaging (CI) in patients with neuroendocrine tumors (NETs). SSTR PET should …
PET tracers for somatostatin receptor imaging of neuroendocrine tumors: current status and review of the literature
CB Johnbeck, U Knigge, A Kjær - Future oncology, 2014 - Taylor & Francis
Neuroendocrine tumors have shown rising incidence mainly due to higher clinical
awareness and better diagnostic tools over the last 30 years. Functional imaging of …
awareness and better diagnostic tools over the last 30 years. Functional imaging of …
Oncologic PET/MRI, part 1: tumors of the brain, head and neck, chest, abdomen, and pelvis
C Buchbender, TA Heusner… - Journal of Nuclear …, 2012 - Soc Nuclear Med
In oncology, staging forms the basis for prognostic consideration and directly influences
patient care by determining the therapeutic approach. Cross-sectional imaging techniques …
patient care by determining the therapeutic approach. Cross-sectional imaging techniques …
[HTML][HTML] Clinical applications of PET/MRI: current status and future perspectives
F Nensa, K Beiderwellen, P Heusch… - Diagnostic and …, 2014 - ncbi.nlm.nih.gov
Fully integrated positron emission tomography (PET)/magnetic resonance imaging (MRI)
scanners have been available for a few years. Since then, the number of scanner …
scanners have been available for a few years. Since then, the number of scanner …
Gastroenteropancreatic neuroendocrine tumours (GEP-NET)–Imaging and staging
T Baumann, C Rottenburger, G Nicolas… - Best practice & research …, 2016 - Elsevier
Detection of gastroenteropancreatic neuroendocrine tumours (GEP-NETs) and monitoring of
treatment response relies mainly on morphological imaging such as computed tomography …
treatment response relies mainly on morphological imaging such as computed tomography …
The Utility of 68Ga-DOTATATE Positron-Emission Tomography/Computed Tomography in the Diagnosis, Management, Follow-Up and Prognosis of Neuroendocrine …
A Tirosh, E Kebebew - Future Oncology, 2017 - Taylor & Francis
Neuroendocrine tumors (NETs) are rare neoplasms that emerge mainly from the GI tract,
pancreas and respiratory tract. The incidence of NETs has increased more than sixfold in the …
pancreas and respiratory tract. The incidence of NETs has increased more than sixfold in the …
Simultaneous 68Ga-DOTA-TOC PET/MRI with gadoxetate disodium in patients with neuroendocrine tumor
TA Hope, MH Pampaloni, E Nakakura, H VanBrocklin… - Abdominal …, 2015 - Springer
Objective To evaluate a simultaneous PET/MRI approach to imaging patients with
neuroendocrine tumor using a combination of 68 Ga-DOTA-TOC as a PET contrast agent …
neuroendocrine tumor using a combination of 68 Ga-DOTA-TOC as a PET contrast agent …